Literature DB >> 33176461

Determinants of Value in Coronary Artery Bypass Grafting.

Alexander A Brescia1,2, Joceline V Vu3, Chang He4, Jun Li5, Steven D Harrington, Michael P Thompson1,2,4,6, Edward C Norton2,7,8,6, Scott E Regenbogen2,3,6, John D Syrjamaki3,6, Richard L Prager1,4, Donald S Likosky1,2,4.   

Abstract

Background Over 180 000 coronary artery bypass grafting (CABG) procedures are performed annually, accounting for $7 to $10 billion in episode expenditures. Assessing tradeoffs between spending and quality contributing to value during 90-day episodes has not been conducted but is essential for success in bundled reimbursement models. We, therefore, identified determinants of variability in hospital 90-day episode value for CABG. Methods Medicare and private payor admissions for isolated CABG from 2014 to 2016 were retrospectively linked to clinical registry data for 33 nonfederal hospitals in Michigan. Hospital composite risk-adjusted complication rates (≥1 National Quality Forum-endorsed, Society of Thoracic Surgeons measure: deep sternal wound infection, renal failure, prolonged ventilation >24 hours, stroke, re-exploration, and operative mortality) and 90-day risk-adjusted, price-standardized episode payments were used to categorize hospitals by value by defining the intersection between complications and spending. Results Among 2573 total patients, those at low- versus high-value hospitals had a higher percentage of prolonged length of stay >14 days (9.3% versus 2.4%, P=0.006), prolonged ventilation (17.6% versus 4.8%, P<0.001), and operative mortality (4.8% versus 0.6%, P=0.001). Mean total episode payments were $51 509 at low-compared with $45 526 at high-value hospitals (P<0.001), driven by higher readmission ($3675 versus $2177, P=0.005), professional ($7462 versus $6090, P<0.001), postacute care ($7315 versus $5947, P=0.031), and index hospitalization payments ($33 474 versus $30 800, P<0.001). Among patients not experiencing a complication or 30-day readmission (1923/2573, 74.7%), low-value hospitals had higher inpatient evaluation and management payments ($1405 versus $752, P<0.001) and higher utilization of inpatient rehabilitation (7% versus 2%, P<0.001), but lower utilization of home health (66% versus 73%, P=0.016) and emergency department services (13% versus 17%, P=0.034). Conclusions To succeed in emerging bundled reimbursement programs for CABG, hospitals and physicians should identify strategies to minimize complications while optimizing inpatient evaluation and management spending and use of inpatient rehabilitation, home health, and emergency department services.

Entities:  

Keywords:  coronary artery bypass; hospitalization; inpatient; length of stay; pneumonia

Mesh:

Year:  2020        PMID: 33176461      PMCID: PMC8041058          DOI: 10.1161/CIRCOUTCOMES.119.006374

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN: 1941-7713


  24 in total

1.  Variation in hospital mortality associated with inpatient surgery.

Authors:  Amir A Ghaferi; John D Birkmeyer; Justin B Dimick
Journal:  N Engl J Med       Date:  2009-10-01       Impact factor: 91.245

2.  The Society of Thoracic Surgeons Adult Cardiac Surgery Database: 2019 Update on Outcomes and Quality.

Authors:  Richard S D'Agostino; Jeffrey P Jacobs; Vinay Badhwar; Felix G Fernandez; Gaetano Paone; David W Wormuth; David M Shahian
Journal:  Ann Thorac Surg       Date:  2018-11-10       Impact factor: 4.330

3.  Drivers of Payment Variation in 90-Day Coronary Artery Bypass Grafting Episodes.

Authors:  Vinay Guduguntla; John D Syrjamaki; Chad Ellimoottil; David C Miller; Richard L Prager; Edward C Norton; Patricia Theurer; Donald S Likosky; James M Dupree
Journal:  JAMA Surg       Date:  2018-01-01       Impact factor: 14.766

4.  Returns to physician human capital: evidence from patients randomized to physician teams.

Authors:  Joseph J Doyle; Steven M Ewer; Todd H Wagner
Journal:  J Health Econ       Date:  2010-08-24       Impact factor: 3.883

5.  Prices don't drive regional Medicare spending variations.

Authors:  Daniel J Gottlieb; Weiping Zhou; Yunjie Song; Kathryn Gilman Andrews; Jonathan S Skinner; Jason M Sutherland
Journal:  Health Aff (Millwood)       Date:  2010-01-28       Impact factor: 6.301

6.  Cost, quality, and value in coronary artery bypass grafting.

Authors:  Ruben L Osnabrugge; Alan M Speir; Stuart J Head; Philip G Jones; Gorav Ailawadi; Clifford E Fonner; Edwin Fonner; A Pieter Kappetein; Jeffrey B Rich
Journal:  J Thorac Cardiovasc Surg       Date:  2014-08-06       Impact factor: 5.209

7.  Bundled Payments in Cardiac Surgery: Is Risk Adjustment Sufficient to Make It Feasible?

Authors:  Kenan W Yount; James M Isbell; Casey Lichtendahl; Zachary Dietch; Gorav Ailawadi; Irving L Kron; John A Kern; Christine L Lau
Journal:  Ann Thorac Surg       Date:  2015-07-21       Impact factor: 4.330

8.  Association Between Postoperative Pneumonia and 90-Day Episode Payments and Outcomes Among Medicare Beneficiaries Undergoing Cardiac Surgery.

Authors:  Michael P Thompson; Lourdes Cabrera; Raymond J Strobel; Steven D Harrington; Min Zhang; Xiaoting Wu; Richard L Prager; Donald S Likosky
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2018-09

9.  Sources of Variation in Hospital-Level Infection Rates After Coronary Artery Bypass Grafting: An Analysis of The Society of Thoracic Surgeons Adult Heart Surgery Database.

Authors:  Donald S Likosky; Amelia S Wallace; Richard L Prager; Jeffrey P Jacobs; Min Zhang; Steven D Harrington; Paramita Saha-Chaudhuri; Patricia F Theurer; Astrid Fishstrom; Rachel S Dokholyan; David M Shahian; J Scott Rankin
Journal:  Ann Thorac Surg       Date:  2015-08-28       Impact factor: 4.330

10.  Understanding variability in hospital-specific costs of coronary artery bypass grafting represents an opportunity for standardizing care and improving resource use.

Authors:  Arman Kilic; Ashish S Shah; John V Conte; Kaushik Mandal; William A Baumgartner; Duke E Cameron; Glenn J R Whitman
Journal:  J Thorac Cardiovasc Surg       Date:  2013-10-05       Impact factor: 5.209

View more
  2 in total

1.  The role of immature platelet count and immature platelet fraction in determining the need for transfusion in patients undergoing CABG.

Authors:  Cihan Yücel; Serkan Ketenciler; Hüseyin Gemalmaz; Nihan Kayalar
Journal:  Cardiovasc J Afr       Date:  2021-09-20       Impact factor: 0.802

2.  Defining value in cardiac surgery: A contemporary analysis of cost variation across the United States.

Authors:  Joseph Hadaya; Yas Sanaiha; Zachary Tran; Richard J Shemin; Peyman Benharash
Journal:  JTCVS Open       Date:  2022-04-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.